BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 10103211)

  • 21. Antimicrobial therapy of experimental meningitis caused by Streptococcus pneumoniae strains with different susceptibilities to penicillin.
    McCracken GH; Sakata Y
    Antimicrob Agents Chemother; 1985 Feb; 27(2):141-5. PubMed ID: 3845793
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activity of CP 99,219 (trovafloxacin) compared with ciprofloxacin, sparfloxacin, clinafloxacin, lomefloxacin and cefuroxime against ten penicillin-susceptible and penicillin-resistant pneumococci by time-kill methodology.
    Visalli MA; Jacobs MR; Appelbaum PC
    J Antimicrob Chemother; 1996 Jan; 37(1):77-84. PubMed ID: 8647777
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacodynamics of vancomycin for the treatment of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis.
    Ahmed A; Jafri H; Lutsar I; McCoig CC; Trujillo M; Wubbel L; Shelton S; McCracken GH
    Antimicrob Agents Chemother; 1999 Apr; 43(4):876-81. PubMed ID: 10103194
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Experimental study of the efficacy of vancomycin, rifampicin and dexamethasone in the therapy of pneumococcal meningitis.
    Martínez-Lacasa J; Cabellos C; Martos A; Fernández A; Tubau F; Viladrich PF; Liñares J; Gudiol F
    J Antimicrob Chemother; 2002 Mar; 49(3):507-13. PubMed ID: 11864951
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Penicillin-resistant Streptococcus pneumoniae endocarditis: a case report and review.
    Siegel M; Timpone J
    Clin Infect Dis; 2001 Mar; 32(6):972-4. PubMed ID: 11247720
    [TBL] [Abstract][Full Text] [Related]  

  • 26. BMS-284756 in experimental cephalosporin-resistant pneumococcal meningitis.
    Rodriguez-Cerrato V; Ghaffar F; Saavedra J; Michelow IC; Hardy RD; Iglehart J; Olsen K; McCracken GH
    Antimicrob Agents Chemother; 2001 Nov; 45(11):3098-103. PubMed ID: 11600362
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Linezolid against penicillin-sensitive and -resistant pneumococci in the rabbit meningitis model.
    Cottagnoud P; Gerber CM; Acosta F; Cottagnoud M; Neftel K; Täuber MG
    J Antimicrob Chemother; 2000 Dec; 46(6):981-5. PubMed ID: 11102418
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of fosfomycin alone and in combination with ceftriaxone or vancomycin in an experimental model of meningitis caused by two strains of cephalosporin-resistant Streptococcus pneumoniae.
    Ribes S; Taberner F; Domenech A; Cabellos C; Tubau F; Liñares J; Viladrich PF; Gudiol F
    J Antimicrob Chemother; 2006 May; 57(5):931-6. PubMed ID: 16507562
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of antimicrobial regimens for treatment of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis.
    Friedland IR; Paris M; Ehrett S; Hickey S; Olsen K; McCracken GH
    Antimicrob Agents Chemother; 1993 Aug; 37(8):1630-6. PubMed ID: 8215275
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative antimicrobial activity of trovafloxacin tested against 3049 Streptococcus pneumoniae isolates from the 1997-1998 respiratory infection season.
    Jones RN; Pfaller MA; Doern GV
    Diagn Microbiol Infect Dis; 1998 Oct; 32(2):119-26. PubMed ID: 9823536
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Trovafloxacin delays the antibiotic-induced inflammatory response in experimental pneumococcal meningitis.
    Nau R; Zysk G; Schmidt H; Fischer FR; Stringaris AK; Stuertz K; Brück W
    J Antimicrob Chemother; 1997 Jun; 39(6):781-8. PubMed ID: 9222048
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The challenge of penicillin-resistant Streptococcus pneumoniae meningitis: current antibiotic therapy in the 1990s.
    Bradley JS; Scheld WM
    Clin Infect Dis; 1997 Feb; 24 Suppl 2():S213-21. PubMed ID: 9126696
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protective effect of trovafloxacin, ciprofloxacin and ampicillin against Streptococcus pneumoniae in a murine sepsis model.
    Lacy MK; Nicolau DP; Banevicius MA; Nightingale CH; Quintiliani R
    J Antimicrob Chemother; 1999 Oct; 44(4):477-81. PubMed ID: 10588309
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ceftriaxone acts synergistically with levofloxacin in experimental meningitis and reduces levofloxacin-induced resistance in penicillin-resistant pneumococci.
    Flatz L; Cottagnoud M; Kühn F; Entenza J; Stucki A; Cottagnoud P
    J Antimicrob Chemother; 2004 Feb; 53(2):305-10. PubMed ID: 14729741
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Moxifloxacin in the therapy of experimental pneumococcal meningitis.
    Schmidt H; Dalhoff A; Stuertz K; Trostdorf F; Chen V; Schneider O; Kohlsdorfer C; Brück W; Nau R
    Antimicrob Agents Chemother; 1998 Jun; 42(6):1397-407. PubMed ID: 9624483
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Killing activities of trovafloxacin alone and in combination with beta-lactam agents, rifampin, or vancomycin against Streptococcus pneumoniae isolates with various susceptibilities to extended-spectrum cephalosporins at concentrations clinically achievable in cerebrospinal fluid.
    Fitoussi F; Doit C; Geslin P; Bingen E
    Antimicrob Agents Chemother; 1999 Oct; 43(10):2372-5. PubMed ID: 10508009
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cefotaxime acts synergistically with levofloxacin in experimental meningitis due to penicillin-resistant pneumococci and prevents selection of levofloxacin-resistant mutants in vitro.
    Kühn F; Cottagnoud M; Acosta F; Flatz L; Entenza J; Cottagnoud P
    Antimicrob Agents Chemother; 2003 Aug; 47(8):2487-91. PubMed ID: 12878509
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quinolone antibiotics in therapy of experimental pneumococcal meningitis in rabbits.
    Nau R; Schmidt T; Kaye K; Froula JL; Täuber MG
    Antimicrob Agents Chemother; 1995 Mar; 39(3):593-7. PubMed ID: 7793857
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Trovafloxacin, a new fluoroquinolone with potent activity against Streptococcus pneumoniae.
    Thomson KS; Chartrand SA; Sanders CC; Block SL
    Antimicrob Agents Chemother; 1997 Feb; 41(2):478-80. PubMed ID: 9021213
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacodynamics of trovafloxacin in a mouse model of cephalosporin-resistant Streptococcus pneumoniae pneumonia.
    Ng W; Lutsar I; Wubbel L; Ghaffar F; Jafri H; McCracken GH; Friedland IR
    J Antimicrob Chemother; 1999 Jun; 43(6):811-6. PubMed ID: 10404320
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.